Genes in MS Patients Bayside NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Esmeralda Mendoza
(201) 656-6475
142 Palisade Ave Ste 109
Jersey City, NJ
Alvin Weseley
(212) 734-7100
877 Park Ave
New York, NY
Magdy Mikhail
(718) 239-8383
1650 Grand Concourse # 5
Bronx, NY
Niaz Ali
(718) 439-1114
5713 5th Ave
Brooklyn, NY
Santha Kamineni
(718) 896-4399
50-11 Queens Blvd #C
Woodside, NY
Albert J Raphael
(212) 724-8181
267 Riversville Rd
Greenwich, CT
Deepali Kothary
(212) 523-4000
1000 10Th Ave # 10
New York, NY
Anthony Francis
(212) 864-6060
111 Central Park North
New York, NY
Lois Eileen Brustman
(718) 920-9647
Our Lady Of Mercy Medical Center 600 E 233rd
Bronx, NY
Moshe Lazar
(718) 645-7337
1421 E 2Nd St
Brooklyn, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Differences Between Hospice and Palliative Care Bayside NY
With as many as 1.5 million Americans seeking hospice treatment in recent years. As a program designed to facilitate “palliative” care for terminally ill patients and their families—many people wonder, what then is the difference between hospice and palliative care, or are they one in the same?
- Side Effect Of Chemotherapy Drugs Bayside NY
- Hospice: Getting Back Control of Your Life Bayside NY
- High Blood Pressure Genes Bayside NY
- Exercise for Chemotherapy Patients Bayside NY
- Doctor-Patient Talk for Hypertension Bayside NY
- Gene Variants and Alzheimer's Risk Bayside NY
- Gene Therapy for Parkinson's Bayside NY
- Genetic Clues for Skin Cancer Therapies Bayside NY
- Depression in Heart Disease Patients Bayside NY